Invasion-inhibitory antibodies elicited by immunization with Plasmodium vivax apical membrane antigen-1 expressed in Pichia pastoris yeast

Infection and Immunity

Volumn 82, Issue 3, 2014, Pages 1296-1307

  Vicentin, Elaine C ^a   Françoso, Kátia S ^a   Rocha, Mariana V ^a   Iourtov, Dmitri ^b   dos Santos, Fernanda L ^b   Kubrusly, Flávia S ^b   Sakauchi, Maria A ^b   Raw, Isaias ^b   Nosten, Francois ^c,d,e   Rénia, Laurent ^f   Rodrigues, Mauricio M ^g   Russell, Bruce ^f,h   Soares, Irene S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

^c SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^d MAHIDOL OXFORD TROPICAL MEDICINE RESEARCH UNIT   (Thailand)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f AGENCY FOR SCIENCE   (Singapore)

^g FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^h NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY FORMATION; ANTIGENS, PROTOZOAN; FEMALE; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; MALARIA VACCINES; MALARIA, VIVAX; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; PICHIA; PLASMODIUM VIVAX; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; YEASTS;

EID: 84894245008     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01169-13     Document Type: Article

References (44)

1. Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, Alonso PL, Del Portillo HA. 2009. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect. Dis. 9:555-566. http: //dx.doi.org/10.1016/S1473-3099(09)70177-X.
2. Lacerda MVG, Mourão MPG, Alexandre MAA, Siqueira AM, Magalhães BML, Martinez-Espinosa FE, Filho FSS, Brasil P, Ventura AMRS, Tada MS, Couto VSCD, Silva AR, Silva RSU, Alecrim MGC. 2012. Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature. Malar. J. 11:12. http://dx.doi.org/10.1186/1475-2875-11-12.
3. Remarque EJ, Faber BW, Kocken CHM, Thomas AW. 2008. Apical membrane antigen 1: a malaria vaccine candidate in review. Trends Parasitol. 24:74-84. http://dx.doi.org/10.1016/j.pt.2007.12.002.
4. Silvie O, Franetich JF, Charrin S, Mueller MS, Siau A, Bodescot M, Rubinstein E, Hannoun L, Charoenvit Y, Kocken CH, Thomas AW, Van Gemert GJ, Sauerwein RW, Blackman MJ, Anders RF, Pluschke G, Mazier D. 2004. A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. J. Biol. Chem. 279: 9490-9496. http://dx.doi.org/10.1074/jbc.M311331200.
5. Bannister LH, Hopkins JM, Dluzewski AR, Margos G, Williams IT, Blackman MJ, Kocken CH, Thomas AW, Mitchell GH. 2003. Plasmo-dium falciparum apical membrane antigen 1 (PfAMA-1) is translocated within micronemes along subpellicular microtubules during merozoite development. J. Cell Sci. 116:3825-3834. http://dx.doi.org/10.1242/jcs .00665.
6. Srinivasan P, Beatty WL, Diouf A, Herrera R, Ambroggio X, Moch JK, Tyler JS, Narum DL, Pierce SK, Boothroyd JC, Haynes JD, Miller LH.2011. Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion. Proc. Natl. Acad. Sci. U. S. A. 108:13275-13280. http://dx.doi.org/10.1073/pnas.1110303108.
7. Collins CR, Withers-Martinez C, Hackett F, Blackman MJ. 2009. An inhibitory antibody blocks interactions between components of the malarial invasion machinery. PLoS Pathog. 5:e1000273. http://dx.doi.org/10 .1371/journal.ppat.1000273.
8. Richard D, MacRaild CA, Riglar DT, Chan J-A, Foley M, Baum J, Ralph SA, Norton RS, Cowman AF, Raymond S. 2010. Interaction between Plasmodium falciparum apical membrane antigen 1 and the rhoptry neck protein complex defines a key step in the erythrocyte invasion process of malaria parasites. J. Biol. Chem. 285:14815-14822. http://dx.doi.org/10 .1074/jbc.M109.080770.
9. Giovannini D, Späth S, Lacroix C, Perazzi A, Bargieri D, Lagal V, Lebugle C, Combe A, Thiberge S, Baldacci P, Tardieux I, Ménard R.2011. Independent roles of apical membrane antigen 1 and rhoptry neck proteins during host cell invasion by apicomplexa. Cell Host Microbe 10:591-602. http://dx.doi.org/10.1016/j.chom.2011.10.012.
10. Kocken CH, Dubbeld MA, Van Der Wel A, Pronk JT, Waters AP, Langermans JA, Thomas AW. 1999. High-level expression of Plasmodium vivax apical membrane antigen 1 (AMA-1) in Pichia pastoris: strong immunogenicity in Macaca mulatta immunized with P. vivax AMA-1 and adjuvant SBAS2. Infect. Immun. 67:43-49.
11. Polley SD, Conway DJ. 2001. Strong diversifying selection on domains of the Plasmodium falciparum apical membrane antigen 1 gene. Genetics 158:1505-1512.
12. Cortés A, Mellombo M, Masciantonio R, Murphy VJ, Reeder JC, Anders RF. 2005. Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1. Infect. Immun. 73:422-430. http://dx.doi.org/10.1128/IAI.73.1.422-430 .2005.
13. Chenet SM, Tapia LL, Escalante AA, Durand S, Lucas C, Bacon DJ.2012. Genetic diversity and population structure of genes encoding vaccine candidate antigens of Plasmodium vivax. Malar. J. 11:68. http://dx .doi.org/10.1186/1475-2875-11-68.
14. Thakur A, Alam MT, Bora H, Kaur P, Sharma YD. 2008. Plasmodium vivax: sequence polymorphism and effect of natural selection at apical membrane antigen 1 (PvAMA1) among Indian population. Gene 419:35-42. http://dx.doi.org/10.1016/j.gene.2008.04.012.
15. Lopez AC, Ortiz A, Coello J, Sosa-Ochoa W, Torres REM, Banegas EI, Jovel I, Fontecha GA. 2012. Genetic diversity of Plasmodium vivax and Plasmodium falciparum in Honduras. Malaria J. 11:391. http://dx.doi.org /10.1186/1475-2875-11-391.
16. Putaporntip C, Jongwutiwes S, Grynberg P, Cui L, Hughes AL. 2009. Nucleotide sequence polymorphism at the apical membrane antigen-1 locus reveals population history of Plasmodium vivax in Thailand. Infect. Genet. Evol. 9:1295-1300. http://dx.doi.org/10.1016/j.meegid.2009.07 .005.
17. Zakeri S, Sadeghi H, Mehrizi AA, Djadid ND. 2013. Population genetic structure and polymorphism analysis of gene encoding apical membrane antigen-1 (AMA-1) of Iranian Plasmodium vivax wild isolates. Acta Trop. 126:269-279. http://dx.doi.org/10.1016/j.actatropica.2013.02.017.
18. Ouattara A, Mu J, Takala-Harrison S, Saye R, Sagara I, Dicko A, Niangaly A, Duan J, Ellis RD, Miller LH, Su X, Plowe CV, Doumbo OK.2010. Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine. Malar. J. 9:175. http://dx.doi.org/10.1186/1475-2875-9-175.
19. Duncan CJ. Sheehy SH, Ewer KJ, Douglas AD, Collins KA, Halstead FD, Elias SC, Lillie PJ, Rausch K, Aebig J, Miura K, Edwards NJ, Poulton ID, Hunt-Cooke A, Porter DW, Thompson FM, Rowland R, Draper SJ, Gilbert SC, Fay MP, Long CA, Zhu D, Wu Y, Martin LB, Anderson CF, Lawrie AM, Hill AVS, Ellis RD. 2011. Impact on malaria parasite multiplication rates in infected volunteers of the protein-inadjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909. PLoS One 6:e22271. http://dx.doi.org/10.1371/journal.pone.0022271.
20. Thera MA, Doumbo OK, Coulibaly D, Laurens MB, Ouattara A, Kone AK, Guindo AB, Traore K, Traore I, Kouriba B, Diallo DA, Diarra I, Daou M, Dolo A, Tolo Y, Sissoko MS, Niangaly A, Sissoko M, Takala-Harrison S, Lyke KE, Wu Y, Blackwelder WC, Godeaux O, Vekemans J, Dubois M-C, Ballou WR, Cohen J, Thompson D, Dube T, Soisson L, Diggs CL, House B, Lanar DE, Dutta S, Heppner DG, Plowe CV. 2011. A field trial to assess a blood-stage malaria vaccine. N. Engl. J. Med. 365: 1004-1013. http://dx.doi.org/10.1056/NEJMoa1008115.
21. Sheehy SH, Duncan CJA, Elias SC, Biswas S, Collins KA, O'Hara GA, Halstead FD, Ewer KJ, Mahungu T, Spencer AJ, Miura K, Poulton ID, Dicks MDJ, Edwards NJ, Berrie E, Moyle S, Colloca S, Cortese R, Gantlett K, Long CA, Lawrie AM, Gilbert SC, Doherty T, Nicosia A, Hill AVS, Draper SJ. 2012. Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors. PLoS One 7:e31208. http: //dx.doi.org/10.1371/journal.pone.0031208.
22. Chuang I, Sedegah M, Cicatelli S, Spring M, Polhemus M, Tamminga C, Patterson N, Guerrero M, Bennett JW, McGrath S, Ganeshan H, Belmonte M, Farooq F, Abot E, Banania JG, Huang J, Newcomer R, Rein L, Litilit D, Richie NO, Wood C, Murphy J, Sauerwein R, Hermsen CC, McCoy AJ, Kamau E, Cummings J, Komisar J, Sutamihardja A, Shi M, Epstein JE, Maiolatesi S, Tosh D, Limbach K, Angov E, Bergmann-Leitner E, Bruder JT, Doolan DL, King CR, Carucci D, Dutta S, Soisson L, Diggs C, Hollingdale MR, Ockenhouse CF, Richie TL. 2013. DNA prime/adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity. PLoS One 8:e55571. http://dx.doi.org/10.1371/journal.pone.0055571.
23. Rodrigues MHC, Rodrigues KM, Oliveira TR, Cômodo AN, Rodrigues MM, Kocken CHM, Thomas AW, Soares IS. 2005. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1. Int. J. Parasitol. 35:185-192. http://dx.doi.org/10 .1016/j.ijpara.2004.11.003.
24. Morais CG, Soares IS, Carvalho LH, Fontes CJF, Krettli AU, Braga EM.2006. Antibodies to Plasmodium vivax apical membrane antigen 1: persistence and correlation with malaria transmission intensity. Am. J. Trop. Med. Hyg. 75:582-587.
25. Barbedo MB, Ricci R, Jimenez MCS, Cunha MG, Yazdani SS, Chitnis CE, Rodrigues MM, Soares IS. 2007. Comparative recognition by human IgG antibodies of recombinant proteins representing three asexual erythrocytic stage vaccine candidates of Plasmodium vivax. Mem. Inst. Oswaldo Cruz 102:335-339. http://dx.doi.org/10.1590/S0074-02762007005000040.
26. Múfalo BC, Gentil F, Bargieri DY, Costa FTM, Rodrigues MM, Soares IS. 2008. Plasmodium vivax apical membrane antigen-1: comparative recognition of different domains by antibodies induced during natural human infection. Microbes Infect. 10:1266-1273. http://dx.doi.org/10 .1016/j.micinf.2008.07.023.
27. Bouillet LéM, Dias MO, Dorigo NA, Moura AD, Russell B, Nosten F, Renia L, Braga EM, Gazzinelli RT, Rodrigues MM, Soares IS, Bruna-Romero O. 2011. Long-term humoral and cellular immune responses elicited by a heterologous Plasmodium vivax apical membrane antigen 1 protein prime/adenovirus boost immunization protocol. Infect. Immun. 79:3642-3652. http://dx.doi.org/10.1128/IAI.05048-11.
28. Soares IS, Rodrigues MM. 2002. Immunogenic properties of the Plasmodium vivax vaccine candidate MSP1(19) expressed as a secreted nonglycosylated polypeptide from Pichia pastoris. Parasitology 124:237-246. http://dx.doi.org/10.1017/S003118200100110X.
29. Ramos CHI. 2004. A spectroscopic-based laboratory experiment for protein conformational studies. Biochem. Mol. Biol. Educ. 32:31-34. http: //dx.doi.org/10.1002/bmb.2004.494032010309.
30. Boscardin SB, Kinoshita SS, Fujimura AE, Rodrigues MM. 2003. Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection. Infect. Immun. 71:2744-2757. http://dx.doi.org/10.1128/IAI.71.5.2744-2757.2003.
31. Costa F, Franchin G, Pereira-Chioccola VL, Ribeirão M, Schenkman S, Rodrigues MM. 1998. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice. Vaccine 16:768-774. http://dx.doi.org/10.1016/S0264-410X(97)00277-6.
32. Quintilio W, Kubrusly FS, Iourtov D, Miyaki C, Sakauchi MA, Lúcio F, Dias SDC, Takata CS, Miyaji EN, Higashi HG, Leite LCC, Raw I. 2009. Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice. Vaccine 27:4219-4224. http://dx .doi.org/10.1016/j.vaccine.2009.04.047.
33. Gentil F, Bargieri DY, Leite JA, Françoso KS, Patricio MBM, Espíndola NM, Vaz AJ, Palatnik-de-Sousa CB, Rodrigues MM, Costa FTM, Soares IS. 2010. A recombinant vaccine based on domain II of Plasmodium vivax apical membrane antigen 1 induces high antibody titres in mice. Vaccine 28:6183-6190. http://dx.doi.org/10.1016/j.vaccine.2010.07.017.
34. Rodrigues MHC, Cunha MG, Machado RL, Ferreira OC, Rodrigues MM, Soares IS. 2003. Serological detection of Plasmodium vivax malaria using recombinant proteins corresponding to the 19-kDa C-terminal region of the merozoite surface protein-1. Malar. J. 2:39. http://dx.doi.org /10.1186/1475-2875-2-39.
35. Sriprawat K, Kaewpongsri S, Suwanarusk R, Leimanis ML, Lek-Uthai U, Phyo AP, Snounou G, Russell B, Renia L, Nosten F. 2009. Effective and cheap removal of leukocytes and platelets from Plasmodium vivax infected blood. Malar. J. 8:115. http://dx.doi.org/10.1186/1475-2875-8-115.
36. Russell B, Suwanarusk R, Malleret B, Costa FTM, Snounou G, Kevin Baird J, Nosten F, Rénia L. 2012. Human ex vivo studies on asexual Plasmodium vivax: the best way forward. Int. J. Parasitol. 42:1063-1070. http://dx.doi.org/10.1016/j.ijpara.2012.08.010.
37. Russell B, Suwanarusk R, Borlon C, Costa FTM, Chu CS, Rijken MJ, Sriprawat K, Warter L, Koh EGL, Malleret B, Colin Y, Bertrand O, Adams JH, D'Alessandro U, Snounou G, Nosten F, Rénia L. 2011. A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax. Blood 118:e74-e81. http://dx.doi.org/10.1182/blood-2011-04-348748.
38. Malleret B, Claser C, Ong ASM, Suwanarusk R, Sriprawat K, Howland SW, Russell B, Nosten F, Rénia L. 2011. A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development. Sci. Rep. 1:118. http://dx.doi.org/10.1038/srep00118.
39. Pizarro JC, Vulliez Le Normand B, Chesne-Seck ML, Collins CR, Withers-Martinez C, Hackett F, Blackman MJ, Faber BW, Remarque EJ, Kocken CHM, Thomas AW, Bentley GA. 2005. Crystal structure of the malaria vaccine candidate apical membrane antigen 1. Science (New York, NY) 308:408-411. http://dx.doi.org/10.1126/science.1107449.
40. Precioso AR, Miraglia JL, Campos LMA, Goulart AC, Timenetsky MC, Cardoso MR, Luna E, Mondini G, Guedes JS, Raw I. 2011. A phase I randomized, double-blind, controlled trial of 2009 influenza A (H1N1) inactivated monovalent vaccines with different adjuvant systems. Vaccine 29:8974-8981. http://dx.doi.org/10.1016/j.vaccine.2011.09.040.
41. Drew DR, Hodder AN, Wilson DW, Foley M, Mueller I, Siba PM, Dent AE, Cowman AF, Beeson JG. 2012. Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria. PLoS One 7:e51023. http://dx .doi.org/10.1371/journal.pone.0051023.
42. Faber BW, Younis S, Remarque EJ, Rodriguez Garcia R, Riasat V, Walraven V, Van der Werff N, Van der Eijk M, Cavanagh DR, Holder AA, Thomas AW, Kocken CHM. 2013. Diversity covering AMA1-MSP119 fusion proteins as malaria vaccines. Infect. Immun. 81:1479-1490. http://dx.doi.org/10.1128/IAI.01267-12.
43. Miura K, Herrera R, Diouf A, Zhou H, Mu J, Hu Z, MacDonald NJ, Reiter K, Nguyen V, Shimp RL, Singh K, Narum DL, Long CA, Miller LH. 2013. Overcoming allelic specificity by immunization with five allelic forms of Plasmodium falciparum apical membrane antigen 1. Infect. Immun. 81:1491-1501. http://dx.doi.org/10.1128/IAI.01414-12.
44. Ouattara A, Takala-Harrison S, Thera MA, Coulibaly D, Niangaly A, Saye R, Tolo Y, Dutta S, Heppner DG, Soisson L, Diggs CL, Vekemans J, Cohen J, Blackwelder WC, Dube T, Laurens MB, Doumbo OK, Plowe CV. 2013. Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications. J. Infect. Dis. 207:511-519. http://dx.doi.org/10.1093/infdis/jis709.